- Home
- MAIA vs TOI Comparison
MAIA vs TOI Comparison
Compare MAIA & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- TOI
- Stock Information
- Founded
- MAIA 2018
- TOI 2007
- Country
- MAIA United States
- TOI United States
- Employees
- MAIA N/A
- TOI N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- TOI Medical/Nursing Services
- Sector
- MAIA Health Care
- TOI Health Care
- Exchange
- MAIA Nasdaq
- TOI Nasdaq
- Market Cap
- MAIA 44.8M
- TOI 49.1M
- IPO Year
- MAIA 2022
- TOI N/A
- Fundamental
- Price
- MAIA $1.48
- TOI $1.26
- Analyst Decision
- MAIA
- TOI
- Analyst Count
- MAIA 0
- TOI 0
- Target Price
- MAIA N/A
- TOI N/A
- AVG Volume (30 Days)
- MAIA 124.0K
- TOI 518.7K
- Earning Date
- MAIA 05-13-2025
- TOI 05-13-2025
- Dividend Yield
- MAIA N/A
- TOI N/A
- EPS Growth
- MAIA N/A
- TOI N/A
- EPS
- MAIA N/A
- TOI N/A
- Revenue
- MAIA N/A
- TOI $393,412,000.00
- Revenue This Year
- MAIA N/A
- TOI $23.95
- Revenue Next Year
- MAIA N/A
- TOI N/A
- P/E Ratio
- MAIA N/A
- TOI N/A
- Revenue Growth
- MAIA N/A
- TOI 21.33
- 52 Week Low
- MAIA $1.46
- TOI $0.13
- 52 Week High
- MAIA $5.99
- TOI $1.63
- Technical
- Relative Strength Index (RSI)
- MAIA 35.67
- TOI 69.32
- Support Level
- MAIA $1.52
- TOI $0.97
- Resistance Level
- MAIA $1.95
- TOI $1.34
- Average True Range (ATR)
- MAIA 0.11
- TOI 0.18
- MACD
- MAIA -0.01
- TOI 0.04
- Stochastic Oscillator
- MAIA 5.09
- TOI 78.85
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.